The invention relates to an anti-RhD monoclonal antibody which is a tetrameric lgG1 immunoglobulin composed of two heavy chains and two light chains the heavy chain comprising the amino acid sequence SEQ ID No. 2 harboring a phenylalanine residue at position 68 and the light chain comprising the amino acid sequence SEQ ID No. 4.